Rikke Rie Hansen

Medicine & Life Sciences

1. Bone Neoplasms 100%
2. Pain 82%
3. Cancer Pain 45%
4. 2-(3-pyridinyl)-1-hydroxyethylidene-1,1-phosphonocarboxylic acid 35%
5. GABA-A Receptors 34%
6. mouse P2rx7 protein 31%
7. Bone and Bones 30%
8. 1-(5-chloro-2,4-dimethoxyphenyl)-3-(5-methylisoxazol-3-yl)urea 30%
9. Neuralgia 26%
10. Purinergic P2X2 Receptors 26%
11. Win 55212-2 24%
12. benzamide 23%
13. Risedronic Acid 23%
14. Quinoxalines 23%
15. Analgesics 23%
16. Purinergic P2X7 Receptors 22%
17. Astrocytes 22%
18. Cannabinoid Receptor Agonists 22%
19. X Ray Crystallography 22%
20. Kainic Acid Receptors 22%
21. Chronic Pain 21%
22. 3'-(5-(1-hydroxy-1-methylethyl)benzoimidazol-1-yl)biphenyl-2-carbonitrile 21%
23. Spinal Cord 19%
24. Hyperalgesia 19%
25. Primary Hyperparathyroidism 19%
26. 7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo(4,3-b)pyridazine 19%
27. AMPA Receptors 19%
28. Carrageenan 19%
29. Diclofenac 19%
30. Calcitonin Gene-Related Peptide 19%
31. Kainic Acid 18%
32. Capsaicin 18%
33. Cholinergic Receptors 17%
34. Nicotinic Receptors 17%
35. Bone Remodeling 16%
36. Tail 15%
37. Theoretical Models 15%